Significant Improvement in Vitiligo With JAK Inhibitor Therapy Durable improvement in pigmentation with topical ruxolitinib, oral ritlecitinib Mar 29, 2022
Atopic Dermatitis: Promising Data for New Mechanistic Approach Rapid responses in a majority of patients in small trial of eblasakimab Mar 28, 2022
Targeted Antibody Provides Significant Relief From Itchy Nodular Condition Dupilumab reduces itch, lesion count in first phase III trial for prurigo nodularis Mar 28, 2022
Dramatic, Durable Hair Growth With Oral JAK Inhibitor Oral baricitinib superior to placebo at 36 weeks in BRAVE-AA1 and BRAVE-AA2 trials Mar 27, 2022
Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitor Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
Topical JAK Inhibitor Shows Promise in Vitiligo Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
High Rate of Hyperhidrosis Relief With Topical Agent Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitor Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
Significant Improvement in Hand Eczema With Pan-JAK Inhibitor Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
Drug 'TYKs' All the Boxes in Two Plaque Psoriasis Trials Significantly higher response rates with TYK2 inhibitor deucravacitinib versus apremilast Apr 25, 2021
Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
Clascoterone Offers Relief in Moderate-to Severe Acne Topical androgen receptor inhibitor led to a decline in inflammatory, non-inflammatory lesions Mar 06, 2019
When Not to Use Biologics for Psoriasis Comorbidities, special populations, idiosyncrasies influence decisions Mar 06, 2019
Do Keloids Convey a Higher Cancer Risk? Taiwanese researchers show association between raised scars and cancers Mar 03, 2019
Injectable Enzyme Promising for Women With Cellulite Collagenase clostridium histolyticum significantly improved cellulite severity on the buttocks Mar 03, 2019
Topical Therapy Improves Hyperhidrosis in Kids Sweat production falls, QOL rises with anticholineregic wipes Feb 20, 2018
Psoriasis Falls to Novel Biologic Bimekizumab brings clear or almost clear skin to vast majority of patients in phase II trial Feb 19, 2018
Risankizumab Resolves Psoriasis in Half of Patients Superior to ustekinumab for many endpoints in two RCTs Feb 19, 2018
Gene Expression Test Impacts Melanoma Management Test assessed high-risk patients based on biological data from 31 genes in tumor tissue Feb 18, 2018
Using Biology of Atopic Dermatitis to Improve Therapy Following psoriasis model of molecular targeting Feb 18, 2018
AAD 2018: Emphasis on 'Adult' Education, Engagement More hands-on sessions, direct participant involvement Feb 16, 2018
Brief, Broad-Area Treatment Clears Actinic Keratosis High patient satisfaction with ingenol disoxate Mar 08, 2017
Transplant Patients Have More Infections After Mohs Surgery Immunosuppressed populations significantly prone to post-procedure complications Mar 08, 2017
Cimzia Passes Muster in Two Psoriasis Trials Met primary efficacy goals versus placebo; third trial still to come Mar 06, 2017
Dramatic Responses to Biologic in Atopic Dermatitis High marks for dual cytokine inhibitor in adults, children Mar 06, 2017
Bacterial Spray Promising for Keratosis Pilaris Topical Nitrosomonas eutropha improved skin texture in small trial Mar 06, 2017
One Biologic Bests Another in Head-to-Head Psoriasis Trial Taltz turns in better results than Stelara on severity indices Mar 05, 2017
Nitric Oxide Gel Shows Promise for Genital Warts Full clearance of baseline warts achieved in phase II trial Mar 05, 2017
AAD: A Skin-Based Test for Alzheimer's Disease? Small study show high Tau protein levels in buccal swabs Mar 05, 2017
New Science, Hot Topics Featured at AAD Meeting First-time sessions account for 25% of program Mar 02, 2017
New Device for Cellulite Tx Offers Lasting Results Patients express long-term satisfaction with tissue stabilized-guided subcision Mar 08, 2016
Anti-IL17A Tx Clears Most Cases of Psoriasis Durable long-term responses with ixekizumab, secukinumab Mar 07, 2016
Positive Data for New Atopic Dermatitis Drugs Topical PDE4 inhibitor, anti-IL-31 antibody improve signs, symptoms Mar 06, 2016
A Tale of Two Psoriasis Numbers: PASI 75 or 90? Debate over complete clearance goals ends in draw Mar 06, 2016
Spironolactone: The 'Other' Hormonal Acne Therapy Expert: drug is effective and its safety issues can be managed Aug 28, 2015
Bed Bug Resurgence a Multifactorial Issue Hygiene, insecticide bans, globalization all contribute Aug 27, 2015
